Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  M. Akbostancı,et al.  Social anxiety in patients with Parkinson's disease. , 2010, The Journal of neuropsychiatry and clinical neurosciences.

[3]  R. Bressan,et al.  Higher dopamine transporter density in Parkinson’s disease patients with depression , 2010, Psychopharmacology.

[4]  S. Loureiro,et al.  Study of the psychometric qualities of the Brief Social Phobia Scale (BSPS) in Brazilian university students , 2010, European Psychiatry.

[5]  R. Narendran,et al.  Dopamine Type 2/3 Receptor Availability in the Striatum and Social Status in Human Volunteers , 2010, Biological Psychiatry.

[6]  D. Aarsland,et al.  Neuropsychiatric symptoms in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[7]  João Ricardo Sato,et al.  Depression in Parkinson's disease: Convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus , 2009, NeuroImage.

[8]  P. Rabins,et al.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[9]  George Mendelson,et al.  Book Reviews , 1995 .

[10]  M. Liebowitz,et al.  Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder , 2009, Depression and anxiety.

[11]  R. Bressan,et al.  Molecular Imaging Studies in Parkinson Disease: Reducing Diagnostic Uncertainty , 2009, The neurologist.

[12]  A. Kummer,et al.  Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[13]  Jaime Kulisevsky,et al.  Cut‐off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Felício,et al.  Genetic and environmental findings in early‐onset Parkinson's disease Brazilian patients , 2008, Movement disorders : official journal of the Movement Disorder Society.

[15]  H. Westenberg,et al.  Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication–Naïve Patients with Generalized Social Anxiety Disorder Shown by 123I-β-(4-Iodophenyl)-Tropane SPECT , 2008, Journal of Nuclear Medicine.

[16]  Dan J Stein,et al.  Social anxiety disorder , 2008, The Lancet.

[17]  M. Liebowitz,et al.  Striatal dopamine D2 receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings , 2008, Depression and anxiety.

[18]  Vesna Sossi,et al.  Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study , 2007, Annals of neurology.

[19]  L. Findley,et al.  The economic impact of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[20]  E. Amaro,et al.  Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?—A [99mTc]‐TRODAT‐1 SPECT study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  Murray B. Stein,et al.  Striatal Function in Generalized Social Phobia: A Functional Magnetic Resonance Imaging Study , 2007, Biological Psychiatry.

[22]  D. Nutt,et al.  Dopamine and social anxiety disorder. , 2006, Revista brasileira de psiquiatria.

[23]  S. Tufik,et al.  Neuroimagem do transportador de dopamina na doença de Parkinson: primeiro estudo com [99mTc]-TRODAT-1 e SPECT no Brasil , 2006 .

[24]  I. Katz,et al.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  M. Mcdermott,et al.  The Ups and Downs of Parkinson Disease: A Prospective Study of Mood and Anxiety Fluctuations , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[26]  G. Colditz,et al.  Association between catechol-O-methyltransferase and phobic anxiety. , 2004, The American journal of psychiatry.

[27]  Yi-Hsin Weng,et al.  Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  L. Werling,et al.  Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine , 2003, Schizophrenia Research.

[29]  M. Liebowitz,et al.  The evidence-based pharmacological treatment of social anxiety disorder. , 2003, The international journal of neuropsychopharmacology.

[30]  Paulo Caramelli,et al.  Sugestões para o uso do mini-exame do estado mental no Brasil , 2003 .

[31]  Ronald C. Kessler,et al.  The impairments caused by social phobia in the general population: implications for intervention , 2003, Acta psychiatrica Scandinavica. Supplementum.

[32]  Ronald C. Kessler,et al.  The National Comorbidity Survey , 2003 .

[33]  J. Davidson,et al.  Efficacy of olanzapine in social anxiety disorder: a pilot study , 2002, Journal of psychopharmacology.

[34]  José Alexandre de Souza Crippa,et al.  Confiabilidade da "Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica" traduzida para o português Reliability of the Structured Clinical Interview for DSM-IV - Clinical Version translated into Portuguese , 2001 .

[35]  M. Liebowitz,et al.  Low dopamine D(2) receptor binding potential in social phobia. , 2000, The American journal of psychiatry.

[36]  M. Höfler,et al.  Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? , 2000, European Psychiatry.

[37]  A. Rossi,et al.  The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. , 1999, The Journal of clinical psychiatry.

[38]  R. Robinson,et al.  Pathophysiology of Secondary Depressions in the Elderly , 1999, Journal of geriatric psychiatry and neurology.

[39]  M. Nader,et al.  Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography , 1998, Synapse.

[40]  R. Bijl,et al.  [Prevalence of mental disorders in persons with Parkinson's disease]. , 1998, Nederlands tijdschrift voor geneeskunde.

[41]  Hank F. Kung,et al.  [99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent , 1997, European Journal of Nuclear Medicine.

[42]  J. Tiihonen,et al.  Dopamine reuptake site densities in patients with social phobia. , 1997, The American journal of psychiatry.

[43]  R. Kessler,et al.  Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. , 1996, Archives of general psychiatry.

[44]  J. Ballenger,et al.  Plasma and CSF HVA levels in panic patients with comorbid social phobia , 1994, Biological Psychiatry.

[45]  Matthew A. Menza,et al.  Parkinson's disease and anxiety: Comorbidity with depression , 1993, Biological Psychiatry.

[46]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[47]  S. Fleminger.  Left-sided Parkinson's disease is associated with greater anxiety and depression , 1991, Psychological Medicine.

[48]  I. Heuser,et al.  Anxiety disorders in patients with Parkinson's disease. , 1990, The American journal of psychiatry.

[49]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[50]  D. Cohen,et al.  School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. , 1981, The American journal of psychiatry.

[51]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[52]  A. Brody,et al.  In vivo brain imaging of human exposure to nicotine and tobacco. , 2009, Handbook of experimental pharmacology.

[53]  Z. Schwab,et al.  Projection technique for evaluating surgery in Parkinson’s disease , 1969 .